Diantha Duvall
Director of Finance/CFO at CURIS, INC.
Net worth: - $ as of 2024-03-30
Profile
Diantha Duvall is currently the Director at BioTheryX, Inc. since 2021 and the CFO, Treasurer & Chief Accounting Officer at Curis, Inc. since 2022.
Previously, she worked as the Executive Director at Merck & Co., Inc. from 2009 to 2015, the Global Commercial Controller at Biogen, Inc. from 2016 to 2017, the Chief Financial Officer at Genocea Biosciences, Inc. from 2019 to 2022, and the Chief Accounting Officer, VP & Controller at Bioverativ, Inc. from 2017 to 2019.
Ms. Duvall completed her undergraduate degree at Colby College and holds a graduate degree and an MBA from Northeastern University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CURIS, INC.
-.--% | 2023-07-30 | 0 ( -.--% ) | - $ | 2024-03-30 |
Diantha Duvall active positions
| Companies | Position | Start |
|---|---|---|
| CURIS, INC. | Director of Finance/CFO | 2022-08-04 |
BioTheryX, Inc.
 BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Director/Board Member | 2021-08-08 |
Former positions of Diantha Duvall
| Companies | Position | End |
|---|---|---|
| GENOCEA BIOSCIENCES, INC. | Director of Finance/CFO | 2022-06-30 |
| BIOVERATIV INC | Comptroller/Controller/Auditor | 2018-12-31 |
| BIOGEN INC. | Corporate Officer/Principal | 2016-12-31 |
| MERCK & CO., INC. | Director/Board Member | 2014-12-31 |
Training of Diantha Duvall
| Colby College | Undergraduate Degree |
| Northeastern University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| CURIS, INC. | Health Technology |
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| Private companies | 2 |
|---|---|
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Health Technology |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Bioverativ, Inc. is a global biopharmaceutical company, focused on discovery, research, development and commercialization of therapies for the treatment of blood diseases including hemophilia. The company is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Diantha Duvall
